Jazz Pharmaceuticals plc buy UBS Group AG
Start price
07.03.25
/
50%
€129.25
Target price
07.03.26
€164.98
Performance (%)
21.43%
End price
08.03.26
€156.95
Summary
This prediction ended on 08.03.26 with a price of €156.95. The BUY prediction by UBS_Group_AG finished with a performance of 21.43%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Jazz Pharmaceuticals plc | -0.797% | -0.797% | 88.411% |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
Comments by UBS_Group_AG for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $179.00 price target on the stock, up previously from $145.00.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten